Misread Biopsy Leads to Delayed Recognition of Urothelial Carcinoma and Bladder Removal

Case Overview

This case involves a patient with recurrent bladder infections. The patient initially had a negative culture and was treated with antibiotics. The physician ordered no imaging or cystoscopy. The patient later presented with blood upon urination and visited his physician. Lab work and CT scan without contrast were done. A biopsy was taken, whereby tumors were removed. Later, the patient was told that the biopsy had been lost and a second biopsy that was required. The biopsy came back and as noninvasive cancer and BCG treatment was recommended. The patient sought a second opinion that reread the slides as being invasive and as urothelial carcinoma of the urinary bladder. Ultimately, the patient’s bladder and prostate had to be removed.

Questions to the Urology expert and their responses

Please elaborate on your experience in the management of patients with possible bladder cancer.

I am an expert in bladder cancer. I have performed over 1400 cystectomies, and am nationally and internationally recognized for my expertise in both early (non-muscle-invasive) as well as muscle-invasive disease. I have been in practice for 26 years, and bladder cancer treatment constitutes about 80% of my clinical practice. I am currently Professor and Director of Urologic Oncology at a major Midwestern medical center.

What diagnostic tests are warranted when a patient presents with recurrent bladder infections and blood upon urination?

Hematuria, gross or microscopic, nearly always requires a urologic evaluation including cytology, cystoscopy, and imaging (typically a CT scan). It is highly unusual that bladder biopsies would be lost. Inaccurate pathological staging, on the other hand, is not that infrequent, whereby one pathologist, often community-based and not specializing in genitourinary pathology, either fails to see muscle invasion or calls it when it is not there. This occurs in my own university-based practice, about 10-15% of the time when I see patients with bladder cancer as second opinions.

About the expert

This highly qualified and board certified urology expert received his M.D from Duke University School of Medicine. He went on to complete a residency in urology at the Harvard Program of Urology and research fellowship at Beth Israel Hospital. He is board certified by the American Board of Urology. This expert is member of several professional organizations including the American Medical Association, American Urological Association, and American Association for Cancer Research. He has received many awards throughout his career including the America?s Top Urologists, Consumers? Research Council of America America?s Top Cancer Doctors, Castle Connolly Medical Ltd.for his services to the profession. He contributes to several peer-review publications including Journal Reviewer at New England Journal of Medicine, JAMA, Journal of Urology, Urology, British Journal of Urology, European Urology, American Journal of Urology Review, Nature Clinical Practice Urology, Nature Clinical Practice Oncology, The Prostate Journal, Urologic Oncology, Cancer, International Journal of Cancer. He is currently a Professor of Urology at a major university an an attending urologist a major university affiliated hospital.

E-008928

Specialties:

Urology